Type 2 diabetes mellitus is characterized by insulin resistance and progressive β cell failure;
therefore, β cell secretagogues are useful for achieving sufficient glycemic control …

In the near future, the majority of patients with diabetes will be adults aged 65 or older.
Unlike young adults with diabetes, elderly diabetic people may be affected by a variety of …

OBJECTIVE To compare ultra-long-acting insulin degludec with glargine for efficacy and
safety in insulin-naive patients with type 2 diabetes inadequately controlled with oral …

The problemdDiabetes is prevalent and chronic (1). A meta-analysis of studies published
between 1990 and 2006 showed that in adults, obesity prevalence increased from 13 to …

Diabetes affects more than 300 million individuals globally, contributing to significant
morbidity and mortality worldwide. As the incidence and prevalence of diabetes continue to …

Aims/hypothesis The aim of this study was to examine the relationship between glycaemic
control and hospitalisation for heart failure in patients with type 2 diabetes. Methods Patients …

Aim To characterize the clinical phenotype of type 2 diabetes mellitus (T2DM) with respect to
age, gender, and BMI. Method Anonymized data of 120 183 people with T2DM from the …

The global burden of type 2 diabetes is growing. Traditional therapies are suboptimal and
there is a clear unmet need for treatments that offer effective glucose control while …

Objectives: The objectives were to estimate the prevalence of self-treated hypoglycaemia in
patients using basal insulin analogues; identify demographic, treatment related and …

Introduction: The cytochrome P4502C enzymes account for the metabolism of approximately
20% of therapeutic drugs including certain oral antidiabetic drugs (OADs). Areas covered …